WQ
RARE icon

Wealth Quarterback’s Ultragenyx Pharmaceutical RARE Stock Holding History

Wealth Quarterback’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10K Hold
100
– – 0.01% 477
2021
Q2 		$10K Buy
+100
New +$10.4K 0.01% 479
2020
Q2 		– Sell
-100
Closed -$4.44K – 606
2020
Q1 		$4.44K Sell
100
-4,248
-98% -$221K ﹤0.01% 639
2019
Q4 		$100 Buy
+4,348
New +$179K ﹤0.01% 977

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Wealth Quarterback's RARE Position: Q3 2021 in Review

Wealth Quarterback held its Ultragenyx Pharmaceutical (RARE) position steady in Q3 2021 at 100 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #477.

Wealth Quarterback first reported a position in RARE in Q4 2019 and has held it in 4 quarters since. 222 funds tracked by Wall St. Rank hold RARE as of Q3 2021.

  • Wealth Quarterback held 100 shares of Ultragenyx Pharmaceutical worth $10K as of Q3 2021.
  • Wealth Quarterback left its Ultragenyx Pharmaceutical share count unchanged in Q3 2021.
  • Ultragenyx Pharmaceutical made up 0.01% of Wealth Quarterback's portfolio in Q3 2021, its #477 holding.
  • Wealth Quarterback first reported a position in Ultragenyx Pharmaceutical in Q4 2019 and has held it in 4 quarters since.
  • 222 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.